CHEK2 is well established as a moderate-risk susceptibility gene for breast cancer, with weaker associations reported for colon and other cancers.28,29,30 The high yield in CHEK2 among individuals with all types of cancer may be in part a result of the high population frequency of the common CHEK2 disease-related variants. This evidence concerns the gene CHEK2 and cancer.